Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus

Blood

Volumn 89, Issue 10, 1997, Pages 3565-3573

  Mori, Takehiko ^a   Ando, Kiyoshi ^b   Tanaka, Kazuo ^b   Ikeda, Yasuo ^b   Koga, Yasuhiro ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FAS ANTIGEN; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; COLONY FORMING UNIT S; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031009675     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3565.3565_3565_3573     Document Type: Article

References (44)

1. Myers JD, Flournoy N, Thomas ED: Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478, 1986
2. Lewis RM, Johnson PC, Golden D, Van Burden CT, Kerman RH, Kahan BD: The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporin-prednisone treated renal allograft recipients. Transplantation 45:353, 1988
3. Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:585, 1988
4. Fiala M, Kattlove H: Cytomegalovirus mononucleosis with severe thrombocytopenia. Ann Intern Med 79:450, 1973
5. Harris A, Meyer RJ, Brody EA: Cytomegalovirus-induced thrombocytopenia and hemolysis in an adult. Ann Intern Med 83:670, 1975
6. Apperley JF, Goldman JM: Cytomegalovirus: Biology, clinical features and methods for diagnosis. Bone Marrow Transplant 3:253, 1988
7. Bilgrami S, Almeida GD, Quinn JJ, Tuck D, Bergstrom S, Dainiak N, Poliquin C, Ascensao JL: Pancytopenia in allogeneic marrow transplant recipients: Role of cytomegalovirus. Br J Haematol 87:357, 1994
8. Verdonck LF, Van Heughten HG, de Gast GC: Delay in platelet recovery after bone marrow transplantation: Impact of cytomegalovirus infection. Blood 66:921, 1985
9. Wingard JR, Chen DY, Burns WH, Fuller DJ, Braine HG, Yeager AM, Kaiser H, Burke PJ, Graham ML, Santos GW, Saral R: Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71:1432, 1988
10. Collier AC, Chandler SH, Handsfield HH, Corey L, McDougall JK: Inhibition of hemopoietic colony formation by human cytomegalovirus in vitro. J Infect Disease 159:127, 1989
11. Sing GK, Ruscetti FW: Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 75:1965, 1990
12. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170, 1992
13. Simmons P, Kaushansky K, Torok-Storb B: Mechanisms of cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87:1386, 1990
14. Lagneaux L, Delforge A, Snoeck R, Stryckmans P, Bron D: Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Exp Hematol 22:26, 1994
15. Hudson JB: The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch Virol 62:1, 1979
16. Matsuzawa H, Shimizu K, Okada K, Ando K, Hashimoto K, Koga Y: Analysis of target organs for the latency of murine cytomgalovirus DNA using specific pathogen free and germfree mice. Arch Virol 140:853, 1995
17. Gibbons AE, Price P, Shellam GR: Analysis of hematopoietic stem and progenitor cell population in cytomegalovirus-infected mice. Blood 86:473, 1995
18. Mutter W, Reddehase MJ, Busch FW, Buhring H-J, Koszinowski UH: Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 167:1645, 1988
19. Koga Y, Tanaka K, Lu Y-Y, Ohtsu M, Sasaki M, Kimura G, Nomoto K: Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J Virol 68:4322, 1994
20. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa S, Miura Y, Suda T: Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706, 1991
21. Ikuta K; Weissman IL: Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89:1502, 1992
22. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Miura Y, Suda T: In vivo and in vitro stem cell function of c-kit-and Sca-1-positive murine hematopoietic cells. Blood 81:3044, 1992
23. Brown J, Greaves MF, Molgaard HV: The gene coding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 3:175, 1991
24. Krause DS, Ito T, Fackler MJ, Smith OM, Collector MI, Sharkis SJ, May WS: Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691, 1994
25. Watanabe-Fukunaga R, Brannan Cl, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274, 1992
26. Jordan MC, Takagi JL: Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect Immun 41:841, 1983
27. Lagneaux L, Deoforge A, Snoeck R, Bosmans E, Moreau JF, Taupin JL, de Clercq E, Stryckmans P, Bron D: Human cytpmegalo-virus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood 87:59, 1996
28. Ishida Y, Furukawa Y, Decaprio JA, Saito M, Griffin JD: Treatment of myeloid leukemic cells with the phosphate inhibitor Okadaic acid induces cell cycle arrest at either G1/S or G2/M depending on dose. J Cell Physiol 150:484, 1992
29. Telford WG, King LE, Fraker PJ: Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24:447, 1991
30. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends-Genet 10:41, 1994
31. Gibbons AE, Price P, Shellam GR: Bone marrow atrophy induced by murine cytomegalovirus. Immunology 82:410, 1994
32. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
33. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 364:806, 1993
34. Peterson PK, Balfour HH Jr, Marker SC, Fryd DS, Howard RJ, Simmons RL: Cytomegalovirus disease in renal allograft recipients: A prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 59:283, 1980
35. Malek TR, Danis KM, Codias EK: Tumor necrosis factor synergistically acts with IFN-γ to regulate Ly-6A/E expression in T lymphocytes, thymocytes and bone marrow cells. J Immunol 142:1929, 1989
36. Dumont FJ, Dijkmans R, Palfree RGE, Bolts RD, Coker L. Selective upregulation by interferon-γ of surface molecules of the Ly-6 complex in resting T cells: The Ly-6A/E and TAP antigens are preferentially enhanced. Eur J Immunol 17:1183, 1987
37. Einhorn L, Einhorn S, Wahren B: Interferon induction in human leukocytes after in vitro exposure to cytomegalovirus or Epstein-Barr virus. Intervirology 23:140, 1985
38. Smith PD, Saini SS, Raffeld M, Manischewitz JE, Wahl SM: Cytomegalovirus induction of tumor necrosis factor-α by human monocytes and mucosal macrophages. J Clin Invest 90:1642, 1992
39. Suda T, Suda J, Ogawa M: Disparate differentiation in mouse hematopoietic colonies derived from paired progenitors. Proc Natl Acad Sci USA 81:2520, 1984
40. + human marrow cells is induced by Interferonγ and tumor necrosis factorα and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3138, 1995
41. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
42. Miller W, Flynn P, McCullough J, Balfour HH, Goldman JA, Haake R, McGlave P, Ramsay N, Kersey J: Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-v-host disease. Blood 67:1162, 1986
43. Neiman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE. Thomas ED: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Disease 136:754, 1977
44. Gratama JW, Middeldorp JM, Sinnige LGF, Van Der Meer JWN, D' Amaro J, Jansen J, Zwaan FE, Brand A, De Gast GC, The TH: Cytomegalovirus immunity in allogeneic marrow grafting. Transplantation 40:510, 1985